ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the young. New research reveals older adults face comparable or higher ...

The Food and Drug Administration has approved the world's only twice-a-year shot to prevent HIV.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

The Food and Drug Administration approved a new, highly effective HIV-prevention medication. The drug nearly eliminated HIV’s spread among people given an injection twice a year in clinical ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial progress. Many effective treatments are available for HIV, but these ...

People with HIV may experience homelessness when they’re shunned by their families or asked to leave their homes, one advocate said.

Researchers at the Department of Medicine, Huddinge, have presented new research on how some people with HIV can control the virus without treatment. The results show that gut bacteria and a ...

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot—lenacapavir—would be given twice a year and ...

Since the first case of HIV in the U.S. nearly 44 years ago, the country has made significant progress towards eradicating the disease. Now on the cusp of ending the epidemic, roadblocks from ...